Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etoricoxib Tablets Post-Marketing Safety and Effectiveness in Osteoarthritis
CTR20132086Phase 4Completed
- Sponsor
- Hengrui Therapeutics
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of etoricoxib in osteoarthritis (OA), sponsored by Hengrui Therapeutics. Started Mar 2014; status: completed.
02
Drugs
etoricoxib
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on CTR20132086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132086.